Clinical efficiency of short and long-term adjuvant therapy of chronic periodontal disease with azithromycin

Nepokupnaia-Slobodianiuk T.S.

Vysshee gosudarstvennoe uchebnoe zavedenie Ukrainy "Ukrainskaia meditsinskaia stomatologicheskaia akademiia", Poltava, 36024

Skripnikov P.N.

Vysshee gosudarstvennoe uchebnoe zavedenie Ukrainy "Ukrainskaia meditsinskaia stomatologicheskaia akademiia", Poltava, 36024

Clinical efficiency of short and long-term adjuvant therapy of chronic periodontal disease with azithromycin

Authors:

Nepokupnaia-Slobodianiuk T.S., Skripnikov P.N.

More about the authors

Journal: Stomatology. 2014;93(6): 20‑24

DOI: 10.17116/stomat201493620-24

Downloaded: 22

Download PDF (RU)

Contact the author

Table of contents

To cite this article:

Nepokupnaia-Slobodianiuk TS, Skripnikov PN. Clinical efficiency of short and long-term adjuvant therapy of chronic periodontal disease with azithromycin. Stomatology. 2014;93(6):20‑24. (In Russ.)
https://doi.org/10.17116/stomat201493620-24

Close metadata

Recommended articles:

The results of the examination of patients with chronic generalized periodontitis after novel coronavirus infection. Russian Journal of Stomatology. 2024;(4):18-22

The purpose of the study was to compare the clinical response to two regimes of azithromycin use in the complex of non-surgical periodontal therapy. After initial periodontal therapy of chronic generalized periodontitis (CGP), 60 patients were randomly assigned to 3 groups. In group 2 and 3 azithromycin was administered: 500 mg 1 time per day, 3 days, and by 500 mg 1 time per day, 7 days, followed by 500 mg 1 time per week for 12 weeks. Clinical indexes were record before treatment and after 1, 3, 6 and 12 months. After 3 months 13 patients in group 1st had the exacerbation of CGP, and only 1 and 2 patients (p<0.05) in the 2nd and 3rd groups, respectively. After 12 months, significantly fewer patients on the 3rd group (as compared with the 1st (p=0.0015) and the 2nd (p=0.0040) had clinical exacerbation. Unscheduled visits were significantly less in the 3rd group as compared with the 1st (χ2=8.03; p=0.0046). The long-term adjunctive azithromycin results in a significantly clinical benefit of 80% patients for 1 year with satisfactory tolerance.

Keywords:

chronic generalized periodontitis

azithromycin

periodontal therapy

Authors:

Nepokupnaia-Slobodianiuk T.S.

Vysshee gosudarstvennoe uchebnoe zavedenie Ukrainy "Ukrainskaia meditsinskaia stomatologicheskaia akademiia", Poltava, 36024

Skripnikov P.N.

Vysshee gosudarstvennoe uchebnoe zavedenie Ukrainy "Ukrainskaia meditsinskaia stomatologicheskaia akademiia", Poltava, 36024

List of references:

Beloklitskaya G.F. Sovremennyi vzglyad na klassifikatsii boleznei parodonta. Otvet na priglashenie k diskussii, prozvuchavshee v stat'e N.F. Danilevskii, A.V. Borisenko "Suchasnі klasifіkatsії zakhvoryuvan' parodontu" v zhurnale "Іmplantologіya, parodontologіya, osteologіya" 2006; 4: 59-62 [Elektronnyi resurs]. Sovremennaya stomatologiya i zubnoe protezirovanie. Rezhim dostupa k zhurn.: http://www.stomatology.org.ua/modules/myarticles/article.php?item_id=2
Shinkevich V.I., Kaidashev I.P. Rol' kletochnykh faktorov immuniteta v remodelirovanii tkanei desny pri khronicheskom generalizovannom parodontite. Stomatologiya 2012; 91: 1: 23: 23-27.
Khomenko L.A., Chaikovskii Yu.B., Savichuk A.V. i dr. Terapevticheskaya stomatologiya detskogo vozrasta. Pod red. L.A. Khomenko. K: Kniga plyus 2007; 68.
Danilevs'kii M.F., Borisenko A.V., Polіtun A.M. ta іn. Terapevtichna stomatologіya u chotir'okh tomakh. Tom 3. Zakhvoryuvannya parodonta [pіdruch. dlya stud. vishch. med. navch. zakl. ІІІ-ІV r.a.]. Pіd red. A.V. Borisenka. K: Meditsina 2008; 614.
Haas A.N., Silva-Boghossian C.M., Colombo A.P. et al. Adjunctive azithromycin in the treatment of aggressive periodontitis: microbiological findings of a 12-month randomized clinical trial. J Dent 2012; 40: 7: 556-563.
Lai P.C., Ho W., N Jain., Walters J.D. Azithromycin concentrations in blood and gingival crevicular fluid after systemic administration. J Periodontol 2011; 82: 11: 1582-1586.
Muniz F.W., de Oliveira C.C., de Sousa Carvalho R. et al. Azithromycin: A new concept in adjuvant treatment of periodontitis. Eur J Pharmacol 2013; 705: 1-3: 135-139.
Sampaio E., Rocha M., Figueiredo L.C. et al. Clinical and microbiological effects of azithromycin in the treatment of generalized chronic periodontitis: a randomized placebo-controlled clinical trial. J Clin Periodontol 2011; 38: 9: 838-846.
Botero J.E., Yepes F.L., Ochoa S.P. et al. Effects of periodontal non-surgical therapy plus azithromycin on glycemic control in patients with diabetes: a randomized clinical trial [Elektronnii resurs]. J Periodontal Res 2013; 27: Doi: 10.1111/jre.12058.
Hirsch R., Deng H., Laohachai M.N. Azithromycin in periodontal treatment: more than an antibiotic. J Periodontal Res 2012; 47: 2: 137-148.
Marsh P.D. Are dental diseases examples of ecological catastrophes? Microbiology 2003; 149: 2: 279-294.
Muhlemann H.R., Son S. Gingival bleeding - a leading symptom in initial gingivitis. Gelvetica odontologica acta 1971; 15: 107-113.
Bassir S.H., Moslemi N., Jamali R. et al. Photoactivated disinfection using light-emitting diode as an adjunct in the management of chronic periodontitis: a pilot double-blind split-mouth randomized clinical trial. Journal of Clinical Periodontology 2013; 40: 1: 65-72.
Wang P.L. Roles of oral bacteria in cardiovascular diseases--from molecular mechanisms to clinical cases: Treatment of periodontal disease regarded as biofilm infection: systemic administration of azithromycin. J Pharmacol Sci 2010; 113: 2: 126-133.

Close metadata